Analyst Ratings for RXO, Inc. (rxo)
rxo Rating Summary
rxo Price Target Summary
- Highest: $35.00 (BMO Capital)
- Lowest: $13.00 (JPMorgan)
- Average: $21.86
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$21.86 (-25.4%)
* Over Last 12-Mos
Rating Score: 2.9 / 10
Percentile Rank: 24%
Avg. $ Target:
$21.86 (-25.4%)
* Over Last 12-Mos
Rating Score: 2.9 / 10
Percentile Rank: 24%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/15/2026 | Citizens | Jeff Kauffman | New Coverage | Market Perform (N/A) |
N/A (N/A) |
27.09 (29.29) |
8.12% | Details |
| 7/13/2026 | BMO Capital | Fadi Chamoun | New Coverage | Outperform (N/A) |
35.00 (N/A) |
26.25 (29.29) |
11.58% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
